Abatacept as GVHD Prophylaxis Phase 2

Clinical trial NCT01743131 · COMPLETED

Trial details

NCT number: NCT01743131
Sponsor: Boston Children's Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Graft vs Host Disease Malignancy

Start date: 2013-02-01
Primary completion: 2018-06-30
Enrollment: 186

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.